Globus Medical, Inc. (GMED)

NYSE: GMED · IEX Real-Time Price · USD
65.82
+0.43 (0.66%)
At close: May 24, 2024, 4:00 PM
67.00
+1.18 (1.79%)
Pre-market: May 28, 2024, 4:06 AM EDT
0.66%
Market Cap 8.89B
Revenue (ttm) 1.90B
Net Income (ttm) 66.63M
Shares Out 135.05M
EPS (ttm) 0.62
PE Ratio 106.16
Forward PE 22.46
Dividend n/a
Ex-Dividend Date n/a
Volume 622,597
Open 65.48
Previous Close 65.39
Day's Range 65.82 - 65.82
52-Week Range 43.39 - 67.37
Beta 1.11
Analysts Buy
Price Target 68.50 (+4.07%)
Earnings Date May 7, 2024

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, tot... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Aug 3, 2012
Employees 5,000
Stock Exchange NYSE
Ticker Symbol GMED
Full Company Profile

Financial Performance

In 2023, Globus Medical's revenue was $1.57 billion, an increase of 53.34% compared to the previous year's $1.02 billion. Earnings were $122.87 million, a decrease of -35.39%.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $68.5, which is an increase of 4.07% from the latest price.

Price Target
$68.5
(4.07% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Globus Medical Reports First Quarter 2024 Results

AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 202...

20 days ago - GlobeNewsWire

Globus Medical Schedules First Quarter Earnings Release and Conference Call

AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31...

5 weeks ago - GlobeNewsWire

Globus Medical Reports Fourth Quarter and Full Year 2023 Results

AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year e...

3 months ago - GlobeNewsWire

Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ...

3 months ago - GlobeNewsWire

Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth

4 months ago - GlobeNewsWire

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quart...

4 months ago - GlobeNewsWire

Globus Medical Reports Third Quarter 2023 Results

AUDUBON, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30...

7 months ago - GlobeNewsWire

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September...

7 months ago - GlobeNewsWire

Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting

Globus Medical presented five-year outcomes from the NuVasive Simplify Cervical Disc study at the North American Spine Society (NASS) 38th Annual Meeting.

7 months ago - GlobeNewsWire

Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum

AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society fo...

8 months ago - GlobeNewsWire

Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023

AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a si...

8 months ago - GlobeNewsWire

Globus Medical Completes Merger with NuVasive

—Creates leading global musculoskeletal company— —Robust portfolio well-positioned for long-term growth and continued innovation—

9 months ago - GlobeNewsWire

Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600

NEW YORK , Aug. 28, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Friday, September 1: Goosehead Insur...

Other symbols: GSHDJXN
9 months ago - PRNewsWire

Globus Medical Reports Second Quarter 2023 Results

AUDUBON, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 202...

10 months ago - GlobeNewsWire

Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company's first product designed specifically for early onset scoliosis

MARVEL™ is Globus Medical's second major release this year in the pediatric scoliosis space MARVEL™ is Globus Medical's second major release this year in the pediatric scoliosis space

10 months ago - GlobeNewsWire

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

AUDUBON, Pa., July 13, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30,...

11 months ago - GlobeNewsWire

Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis

REFLECT™ is approved through the FDA's Humanitarian Device Exemption pathway REFLECT™ is approved through the FDA's Humanitarian Device Exemption pathway

1 year ago - GlobeNewsWire

Globus Medical Reports First Quarter 2023 Results

AUDUBON, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 202...

1 year ago - GlobeNewsWire

Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive

AUDUBON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier...

1 year ago - GlobeNewsWire

NuVasive Shareholders Approve Merger Agreement with Globus Medical

SAN DIEGO , April 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ...

1 year ago - PRNewsWire

Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical

SAN DIEGO , April 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ...

1 year ago - PRNewsWire

NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (...

1 year ago - Business Wire

Globus Medical Reports Fourth Quarter and Full Year 2022 Results

AUDUBON, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year en...

1 year ago - GlobeNewsWire

NUVASIVE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (...

1 year ago - Business Wire